Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
- Add to watchlist
- Create an alert
- This stock can be held in a
940.00p
940.00p
1,034.00p
1,007.29
942.00p
922.00p
715.00p
-5.89%
6.00p (0.63%) Previous:
6.00p
125,516
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 3.88% | 1 year 1Y | 21.39% |
---|---|---|---|
1 month 1M | 1.88% | 2 years 2Y | 1.62% |
3 months 3M | 6.8% | 3 years 3Y | 33.94% |
6 months 6M | 23.14% | 5 years 5Y | 37.32% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.30% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £384m |
Gross gearing: | 13% |
Market capitalisation:Market cap.: | £318m |
Shares in issue: | 33.49 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,007.29 |
---|---|
Latest actual NAV: | 1,007.00 |
Latest actual NAV date: | 17 April 2024 |
Premium/Discount: | -5.89% |
12m average Premium/Discount: | -7.61% |
NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Amgen Inc | 8.75% |
Biogen Inc | 8.46% |
Scholar Rock Holding Corp | 4.83% |
Biomarin Pharmaceutical Inc | 4.70% |
Ionis Pharmaceuticals Inc | 4.36% |
Vaxcyte Inc Ordinary Shares | 4.22% |
Quantumpharm Inc (Xtalpi) - Pfd | 3.75% |
Sarepta Therapeutics Inc | 3.73% |
Neurocrine Biosciences Inc | 3.25% |
Vera Therapeutics Inc Class A | 3.19% |
Sector | Weight |
---|---|
Healthcare | 104.33% |
Country | Weight |
---|---|
United States | 93.97% |
China | 7.38% |
Canada | 1.68% |
Germany | 1.30% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2024 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.